Skip to main content
. Author manuscript; available in PMC: 2020 Mar 5.
Published in final edited form as: Ann Hepatol. 2018 Apr 9;17(3):413–418. doi: 10.5604/01.3001.0011.7385

Table 3.

Factors associated with adherence.

Patient characteristics Unadjusted OR (95% CI) p-value* Adjusted OR (95% CI) p-value*
Age (years) 1.02 (0.99–1.06) 0.219 0.96 (0.92–1.01) 0.086
Male gender 1.10 (0.62–1.97) 0.742 1.17 (0.60–2.28) 0.64
History of substance use 1.09 (0.59–2.01) 0.783
History of psychiatric comorbidity 0.88 (0.51–1.54) 0.661
HIV coinfection 0.63 (0.21–1.87) 0.402
HBV coinfection 0.50 (0.03–8.16) 0.629
Cirrhosis 1.06 (0.41–2.72) 0.91
Decompensated liver disease 2.80 (0.79–9.93) 0.111
≥ 2 Medical comorbidities 3.11 (1.04–9.35) 0.043 1.42 (0.44–4.57) 0.552
Direct acting antiviral agent availability 7.62 (4.12–14.1) < 0.001 10.3 (4.84–22.0) < 0.001
*

p-value < 0.05 considered statistically significant and bolded.

Adjusted for age, gender, and insurance status. OR: odds ratio.

Defined as presence of diabetes, heart disease, or chronic kidney disease (eGFR < 60).